Weighted Average Number of Shares Outstanding, Diluted of Caris Life Sciences, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Caris Life Sciences, Inc. annual and quarterly Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Caris Life Sciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 297,211,838, a 734% increase year-over-year.
  • Caris Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 167,205,616, a 371% increase from 2024.
  • Caris Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 35,496,832, a 1.6% increase from 2023.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Caris Life Sciences, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 167,205,616 +131,708,784 +371% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 35,496,832 +554,141 +1.6% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 34,942,691 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2026 2025 FY

Caris Life Sciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 297,211,838 +261,568,249 +734% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 64,918,988 +29,547,564 +84% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 35,643,589 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 35,371,424 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.